The Sodium Lowering in Dialysate ( SoLID ) trial is an ongoing a multi-center , prospective , randomised , single-blind ( assessor ) , controlled , parallel assignment clinical trial , enrolling 96 home and self-care hemodialysis ( HD ) patients from 7 centers in New Zealand .